BR9913227A - Composições muco-adesivas orais contendo ativos gastrointestinais - Google Patents

Composições muco-adesivas orais contendo ativos gastrointestinais

Info

Publication number
BR9913227A
BR9913227A BR9913227-3A BR9913227A BR9913227A BR 9913227 A BR9913227 A BR 9913227A BR 9913227 A BR9913227 A BR 9913227A BR 9913227 A BR9913227 A BR 9913227A
Authority
BR
Brazil
Prior art keywords
component
composition
assets
gastrointestinal
compositions containing
Prior art date
Application number
BR9913227-3A
Other languages
English (en)
Inventor
Douglas Joseph Dobrozsi
Todd Ehren Vinneau
Christopher Robert Mayer
Kishorkumar Jivanlal Desai
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9913227A publication Critical patent/BR9913227A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>''COMPOSIçõES MUCO-ADESIVAS ORAIS CONTENDO ATIVOS GASTROINTESTINAIS''<D>. A presente invenção se refere a composições muco-adesivas compreendendo uma quantidade segura e eficaz de um ativo gastrointestinal; a partir de cerca de 1,5% a cerca de 10% em peso da composição, de um componente de argila; e a partir de cerca de 0,01% a cerca de 1%, em peso da composição de um componente de goma. Alternativamente, o componente de goma pode ser um componente de dióxido de titânio ou dióxido de silício. As composições muco-adesivas também compreendem preferencialmente até cerca de 2% em peso da composição de um componente não-iónico tam como metil celulose. A presente invenção também se refere a métodos de prevenção e tratamento de distúrbios do trato gastrointestinal em seres humanos ou animais inferiores por meio de administração por via oral de uma composição da presente invenção.
BR9913227-3A 1998-08-24 1999-08-24 Composições muco-adesivas orais contendo ativos gastrointestinais BR9913227A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24
PCT/US1999/019140 WO2000010527A1 (en) 1998-08-24 1999-08-24 Oral mucoadhesive compositions containing gastrointestinal actives

Publications (1)

Publication Number Publication Date
BR9913227A true BR9913227A (pt) 2001-05-22

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913227-3A BR9913227A (pt) 1998-08-24 1999-08-24 Composições muco-adesivas orais contendo ativos gastrointestinais

Country Status (15)

Country Link
US (1) US20010016577A1 (pt)
EP (1) EP1115378A1 (pt)
JP (1) JP2002523352A (pt)
KR (1) KR20010072463A (pt)
CN (1) CN1313755A (pt)
AU (1) AU5685299A (pt)
BR (1) BR9913227A (pt)
CA (1) CA2338688A1 (pt)
CO (1) CO5140071A1 (pt)
HU (1) HUP0103216A2 (pt)
ID (1) ID27728A (pt)
NO (1) NO20010833L (pt)
PE (1) PE20000860A1 (pt)
TR (1) TR200100629T2 (pt)
WO (1) WO2000010527A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
ES2349235T3 (es) * 2001-12-21 2010-12-29 Alcon, Inc. Uso de nanopartículas inorgánicas sintéticas como vehículos para farmacos oftálmicos.
MXPA05003162A (es) * 2002-09-26 2005-07-05 Yamanouchi Pharma Co Ltd Agentes mejoradores de absorbibilidad de droga.
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
HUE038452T2 (hu) 2007-11-13 2018-10-29 Meritage Pharma Inc Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US8865692B2 (en) * 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
CA2770182C (en) * 2009-08-05 2016-09-27 Tyco Healthcare Group Lp Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein and related methods therefor
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
BR112013016210A2 (pt) * 2010-12-23 2019-09-24 Colgate Palmolive Co composições fluidas compreendendo um agente estruturador.
MX342833B (es) 2011-12-15 2016-10-14 Colgate Palmolive Co Composiciones de cuidado oral acuosas.
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
AU2012396256B2 (en) * 2012-12-03 2015-11-19 Colgate-Palmolive Company Manufacturing processes for gellan gum-based fluid gels
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
CA2943422C (en) * 2014-04-29 2020-03-10 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
EP3137059B1 (en) * 2014-04-29 2018-05-23 The Procter and Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
JP6742297B2 (ja) 2014-07-14 2020-08-19 ユニヴァーシティ オブ ユタ リサーチ ファンデーション その場凝固複合コアセルベートならびにその製造および使用方法
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
JP7410876B2 (ja) 2018-01-26 2024-01-10 フルイデックス メディカル テクノロジー,リミティッド ライアビリティ カンパニー 血管閉塞のためにその場凝固複合コアセルベートを使用する装置及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
CN1313755A (zh) 2001-09-19
NO20010833D0 (no) 2001-02-19
CA2338688A1 (en) 2000-03-02
KR20010072463A (ko) 2001-07-31
TR200100629T2 (tr) 2001-07-23
WO2000010527A1 (en) 2000-03-02
US20010016577A1 (en) 2001-08-23
JP2002523352A (ja) 2002-07-30
EP1115378A1 (en) 2001-07-18
HUP0103216A2 (hu) 2002-01-28
AU5685299A (en) 2000-03-14
ID27728A (id) 2001-04-26
CO5140071A1 (es) 2002-03-22
PE20000860A1 (es) 2000-09-11
NO20010833L (no) 2001-02-19

Similar Documents

Publication Publication Date Title
BR9913227A (pt) Composições muco-adesivas orais contendo ativos gastrointestinais
BR9913148A (pt) Composições mucoadesivas lìquidas orais
BR9913178A (pt) Composições mucoadesivas lìquidas orais
ATE345782T1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
DK1121103T3 (da) Oralt disintegrerbare tabletter, der omfatter en benzimidazol
EP1614431A3 (en) Compositions for treatment of disorders of the oesophagus
IL186655A0 (en) Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
WO2006017540A3 (en) Pilocarpine compositions and methods of use thereof
BR0211604A (pt) Inibidores de integrina para o tratamento de doenças do olho
BR0209017A (pt) Novas piridil benzazepina carboxamidas tricìclicas e antagonistas receptores de ocitocina tocolìticos derivados das mesmas
BR0115077A (pt) Métodos e composições para o tratamento de doenças dos olhos
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
BR9913141A (pt) Composições mucoadesivas lìquidas orais
WO2002053099A3 (en) Methods and compositions for treating periodontal disease
TNSN08497A1 (fr) Composition nasale et buccale pour lutter contre le ronflement
JP2007269806A (ja) 人工唾液
BRPI0613058A2 (pt) composição para cuidado oral para a lubrificação da cavidade bucal, uso de um polìmero de poliol de silicone solúvel em água, e, métodos para lubrificar e hidratar a cavidade bucal, e para aliviar os sintomas de xerostomia
BR0005319A (pt) Tratamento combinado para depressão e ansiedade
HUP0003463A2 (hu) Piperidinil-metil-oxazolidinon-származék, eljárás ennek előállítására és a vegyületet tartalmazó gyógyszerkészítmény
JP2007291117A (ja) 人工唾液
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
BR0002381A (pt) Agente para aumentar a liberação de acetilcolina no cérebro
Pršo Brekalo et al. Determination of Mediators PGE2 and TXB2 in saliva of adult patients with periodontitis
NO996580L (no) 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat
UA49889C2 (uk) Антибактеріальний препарат &#34;бороцин&#34;

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4 A 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.